<?xml version="1.0" encoding="UTF-8"?>
<p id="p0085">Natural bioactive compounds induce the activation of apoptotic pathways in cancer cells (
 <xref rid="bib69" ref-type="bibr">Safarzadeh et al., 2014</xref>). Hispolon, an active polyphenolic compound sensitizes cancer cells to trail by activating caspase-3, -8 and -9, reducing Bcl-2, Bcl-xL while upregulating Bax protein (
 <xref rid="bib52" ref-type="bibr">Kim et al., 2016</xref>). In DU145Â cells, hispolon modulates Bcl-2 family proteins leading towards the discharge of cytochrome c that ultimately triggers the cascade of caspases (
 <xref rid="fig7" ref-type="fig">Fig. 7</xref> ) (
 <xref rid="bib60" ref-type="bibr">Masood et al., 2019</xref>). Anticancer efficacy of hispolon is linked with the upregulation of Fas and Fas ligand that stimulates extrinsic apoptotic pathway (
 <xref rid="bib15" ref-type="bibr">Chen et al., 2013</xref>; 
 <xref rid="bib38" ref-type="bibr">Hsieh et al., 2018</xref>). Molecular targets of hispolon, model cell lines used in experimentation, IC
 <sub>50</sub> and treatment conditions are presented in 
 <xref rid="tbl2" ref-type="table">Table 2</xref> .
</p>
